Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

A Study of Bimagrumab (LY3985863) and Tirzepatide (LY3298176), Alone or in Combination, in Participants With Obesity or Overweight With Type 2 Diabetes

ClinicalTrials.gov ID: NCT06901349

Public ClinicalTrials.gov record NCT06901349. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 17, 2026, 7:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b Double-Blind, Randomized, Placebo-Controlled Study of Bimagrumab and Tirzepatide, Alone or in Combination, to Investigate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to see how well and how safely bimagrumab, tirzepatide, and the combination, work in lowering body weight in participants with obesity or overweight and type 2 diabetes. Participation in the study will last about 13 months.

Study identification

NCT ID
NCT06901349
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 23, 2025 (Actual)
Primary completion
Jun 10, 2025 (Actual)
Completion
Jun 10, 2025 (Actual)
Last update posted
Sep 24, 2025

2025

United States locations

U.S. sites
25
U.S. states
14
U.S. cities
25
Facility City State ZIP Site status
Yuma Clinical Trials Yuma Arizona 85364 —
Orange County Research Center Lake Forest California 92630 —
Healthy Brain Clinic Long Beach California 90804 —
Valley Clinical Trials, Inc. Northridge California 91325 —
Diablo Clinical Research, Inc. Walnut Creek California 94598 —
Excel Medical Clinical Trials Boca Raton Florida 33434 —
Clinical Neuroscience Solutions, Inc. dba CNS Healthcare Jacksonville Florida 32256 —
L&C Professional Medical Research Institute Miami Florida 33144 —
Global Health Research Center, Inc. Miami Lakes Florida 33016 —
Charter Research - Winter Park Orlando Florida 32803 —
Charter Research - Lady Lake The Villages Florida 32162 —
Balanced Life Health Care Solutions/SKYCRNG Lawrenceville Georgia 30046 —
East-West Medical Research Institute Honolulu Hawaii 96814 —
Bingham Memorial Hospital Blackfoot Idaho 83221 —
Family First Medical Center Idaho Falls Idaho 83404 —
Deaconess Clinic- Gateway Newburgh Indiana 47630 —
Kur Research - Columbia Medical Columbia Maryland 21045 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
University of North Carolina Medical Center Chapel Hill North Carolina 27514 —
Remington-Davis, Inc Columbus Ohio 43215 —
Central States Research Tulsa Oklahoma 74136 —
Velocity Clinical Research, Dallas Dallas Texas 75230 —
PlanIt Research, PLLC Houston Texas 77079 —
Activian Clinical Research Kingwood Texas 77339 —
Northwest Clinical Research Center Bellevue Washington 98007 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06901349, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 24, 2025 · Synced Oct 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06901349 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →